Compare PRLD & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRLD | TCBS |
|---|---|---|
| Founded | 2016 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.1M | 46.3M |
| IPO Year | 2020 | N/A |
| Metric | PRLD | TCBS |
|---|---|---|
| Price | $1.71 | $16.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 405.6K | 2.8K |
| Earning Date | 11-12-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.87 |
| Revenue | $10,500,000.00 | ★ $15,268,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.09 |
| Revenue Growth | ★ 250.00 | 54.88 |
| 52 Week Low | $0.61 | $14.90 |
| 52 Week High | $4.22 | $19.40 |
| Indicator | PRLD | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 54.14 | 59.10 |
| Support Level | $1.30 | $15.90 |
| Resistance Level | $1.72 | $17.00 |
| Average True Range (ATR) | 0.16 | 0.19 |
| MACD | 0.02 | 0.06 |
| Stochastic Oscillator | 97.65 | 44.00 |
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.